Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Allogeneic Hemopietic Stem Cell Transplants for the Treatment of B Cell Acute Lymphocytic Leukemia

  • Dong, Wei-Min (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University) ;
  • Cao, Xiang-Shan (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University) ;
  • Wang, Biao (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University) ;
  • Lin, Yun (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University) ;
  • Hua, Xiao-Ying (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University) ;
  • Qiu, Guo-Qiang (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University) ;
  • Gu, Wei-Ying (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University) ;
  • Xie, Xiao-Bao (Department of Hematology, The First People's Hospital of Changzhou, Third Affiliated Hospital of Suzhou University)
  • Published : 2014.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: Explore the feasibility of allo-hemopietic stem cell transplants in treating patients with B cell acute lymphocytic leukemia. Methods: Between september 2006 and February 2011, fifteen patients with B cell acute lymphocytic leukemia (ALL) were treated by allo-hemopietic stem cell transplants (HSCT). Stem cell sources were peripheral blood. Six patients were conditioned by busulfan (BU) and cyclophosphamide (CY) and nine patients were conditioned with TBI and cyclophosphamide (CY). Graft versus host disease (GVHD) prophylaxis regimen consisted of cyclosporine A (CSA), methotrex ate (MTX) and mycophenolatemofetil (MMF). Results: Patients received a median of $7.98{\times}10^8{\cdot}kg^{-1}$ ($5.36-12.30{\times}10^8{\cdot}kg^{-1}$) mononuclear cells (MNC). The median time of ANC> $0.5{\times}10^9/L$ was day 12 (10-15), and PLT> $20.0{\times}10^9/L$ was day 13 (11-16). Extensive acute GVHD occurred in 6 (40.0%) patients, and extensive chronic GVHD was recorded in 6 (40.0%) patients. Nine patients were alive after 2.5-65 months follow-up. Conclusion: Allogeneic stem cell transplant could be effective in treating patients with B cell acute lymphocytic leukemia.

Keywords

References

  1. Abdel-Aziz MM et al (2013). Clinical significance of serum p53 and epidermal growth factor receptor in patients with acute leukemia. Asian Pac J Cancer Prev, 14, 4295-9. https://doi.org/10.7314/APJCP.2013.14.7.4295
  2. Chen H, Ren HY, Guo NL, et al (2004). Allogeneic hematopoietic stem cell transplantation in treatment of acute lymphoblastic leukemia. Chin J Hematol, 25, 87-90
  3. Dunna NR, Naushad SM, Vuree S, et al (2014). Association of thymidylate synthase 5'-UTR 28bp tandem repeat and serine hydroxymethyltransfarase C1420T polymorphisms with susceptibility to acute leukemia. Asian Pac J Cancer Prev, 15, 1719-23. https://doi.org/10.7314/APJCP.2014.15.4.1719
  4. Dunna NR, Vure S, Sailaja K, et al (2013). Deletion of GSTM1 and T1 genes as a risk factor for development of acute leukemia. Asian Pac J Cancer Prev, 14, 2221-4. https://doi.org/10.7314/APJCP.2013.14.4.2221
  5. Hunau ltM, Harousseau JL, Delain M, et al (2004). Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial . Blood, 104, 3028 -37 https://doi.org/10.1182/blood-2003-10-3560
  6. Jiang Y, Hou J, Zhang Q, et al (2013). The MTHFR C677T polymorphism and risk of acute lymphoblastic leukemia: an updated meta-analysis based on 37 case-control studies. Asian Pac J Cancer Prev, 14, 6357-62. https://doi.org/10.7314/APJCP.2013.14.11.6357
  7. Li X, Li J, Hu Y, et al (2012). A comprehensive cytogenetic classification of 1466 Chinese patients with de novo acute lymphoblastic leukemia. Leuk Res. Jan 18
  8. Lqbal Z (2014). Molecular genetic studies on 167 pediatric ALL patients from different areas of Pakistan confirm a low frequency of the favorable prognosis fusion oncogene TEL-AML1 (t 12; 21) in underdeveloped countries of the region. Asian Pac J Cancer Prev, 15, 3541-6. https://doi.org/10.7314/APJCP.2014.15.8.3541
  9. Mehde AA, Mehdi WA, Zainulabdeen JA, et al (2014). Correlation of inhibin and several antioxidants in children with acute lymphoblastic leukemia. Asian Pac J Cancer Prev, 15, 4843-6. https://doi.org/10.7314/APJCP.2014.15.12.4843
  10. Masa H, Hiroshi S, Hisashi S, et al (2005). Unrelated donor marrow transplantation for acute lymphoblastic leukemia in japan. Blood (ASH Annual Meeting Abstracts 442), 106, 53-53.
  11. Niu YN, Liu QQ, Zhang SP, et al (2014). Alternative messenger RNA splicing of autophagic gene Beclin 1 in human B-cell acute lymphoblastic leukemia cells. Asian Pac J Cancer Prev, 15, 2153-8. https://doi.org/10.7314/APJCP.2014.15.5.2153
  12. Ozbas-Gerceker F, Bozman N, Gezici S, et al (2013). Association of TAP1 and TAP2 gene polymorphisms with hematological malignancies. Asian Pac J Cancer Prev, 14, 5213-7. https://doi.org/10.7314/APJCP.2013.14.9.5213
  13. Pui CH, Evans WE, Jeha S, et al (2006). Treatment of acute lympblastic leukemia. N Engl J Med, 354, 166-78 https://doi.org/10.1056/NEJMra052603
  14. Rowe JM, Buck G, Burnett AK, et al (2005). Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993. Blood, 106, 3760-7. https://doi.org/10.1182/blood-2005-04-1623
  15. Rowe J (2010). Prognostic factors in adult acute lymphoblastic leukemia. Br J Haematol, 150, 389-405.
  16. Soheila K, Hamid A, Farid Z, et al (2013). Comparison of univariate and multivariate gene set analysis in acute lymphoblastic leukemia. Asian Pac J Cancer Prev, 14, 1629-33. https://doi.org/10.7314/APJCP.2013.14.3.1629
  17. Shaikh MS, Ali SS, Khurshid M, et al (2014). Chromosomal abnormalities in Pakistani children with acute lymphoblastic leukemia. Asian Pac J Cancer Prev, 15, 3907-9. https://doi.org/10.7314/APJCP.2014.15.9.3907
  18. Terwey TH, Kim TD, Arnold RC, et al (2009). hematopoietic stem cell transplantation for adult acute lymphocytic leukemia. Curr Hematol Malig Rep, 4, 139-47. https://doi.org/10.1007/s11899-009-0020-7
  19. Tharnprisan P, Khiewyoo J, Sripraya P, et al (2013). Relapse-free rate with childhood acute lymphoblastic leukemia treated under the thai national protocol. Asian Pac J Cancer Prev, 14, 1127-30. https://doi.org/10.7314/APJCP.2013.14.2.1127
  20. Wang CX, Wang X, Liu HB, et al (2014). Aberrant DNA methylation and epigenetic inactivation of hMSH2 decrease overall survival of acute lymphoblastic leukemia patients via modulating cell cycle and apoptosis. Asian Pac J Cancer Prev, 15, 355-62. https://doi.org/10.7314/APJCP.2014.15.1.355
  21. Xiao Y, Zhang DH, Huang W, et al (2007). Donor stem cell infusion for the treatment of chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation, recurrence, 1 case report and literature review. J Clin Hematol, 20, 135-6.
  22. Yuan CL (2009). Hematopoietic stem cell transplantation treatment of adult acute lymphoblastic leukemia. Shandong Med J, 49, 110-1.

Cited by

  1. T Cells after Allogeneic Hematopoietic Stem Cell Transplantation and its Correlation with Invasive Fungal Infection in Patients with Hematological Malignancies vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3137